Imatinib (Gleevec)

DRUG3 trials

Sponsors

Peking University, University Health Network, Toronto, Kumquat Biosciences Inc.

Conditions

GISTGIST - Gastrointestinal Stromal TumorGIST Metastatic CancerGastro Intestinal Stromal TumourGastrointestinal TumorsLeukemiaMetastatic Melanoma

Phase 1

A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

CompletedNCT01126814

University Health Network, TorontoLeukemia

Start: 2004-07-31End: 2010-04-30Updated: 2015-06-24

Phase 2

Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma

CompletedNCT00881049

Peking UniversityMetastatic Melanoma

Start: 2008-12-31End: 2011-01-31Target: 1Updated: 2011-01-17

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

RecruitingNCT07406633

Kumquat Biosciences Inc.Gastro Intestinal Stromal Tumour, Gastrointestinal Tumors, GIST +2

Start: 2026-06-23End: 2028-10-01Target: 46Updated: 2026-08-10